Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis
- PMID: 17009229
- DOI: 10.1002/art.22117
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis
Abstract
Objective: To determine whether patients with rheumatoid arthritis (RA) have an increased risk of fracture, and to estimate their long-term absolute fracture risk.
Methods: We studied patients with RA ages >or=40 years in the British General Practice Research Database, each matched by age, sex, calendar time, and practice to 3 control patients. Incident fractures, as recorded in the computerized medical records, were ascertained over a median followup of 7.6 years. The fracture rate in RA patients compared with controls was adjusted for smoking, body mass index (BMI), and several clinical risk factors, and Cox proportional hazards models were used to calculate the relative risk (RR) of fracture in RA. A risk score was then developed to provide an estimate of the 5- and 10-year fracture risk among RA patients.
Results: There were 30,262 patients with RA, of whom 2,460 experienced a fracture during followup. Compared with controls, patients with RA had an increased risk of fracture, which was most marked at the hip (RR 2.0, 95% confidence interval [95% CI] 1.8-2.3) and spine (RR 2.4, 95% CI 2.0-2.8). Indicators of a substantially elevated risk of fracture (at the hip) included >10 years' duration of RA (RR 3.4, 95% CI 3.0-3.9), low BMI (RR 3.9, 95% CI 3.1-4.9), and use of oral glucocorticoids (RR 3.4, 95% CI 3.0-4.0). Modeling of the long-term risk profiles revealed that, for example, in a woman age 65 years with longstanding RA whose risk factors also included low BMI, a history of fracture, and frequent use of oral glucocorticoids, the 5-year risk of hip fracture was 5.7% (95% CI 5.3-6.1%).
Conclusion: Patients with RA are at increased risk of osteoporotic fractures. This increased risk is attributable to a combination of disease activity and use of oral glucocorticoids.
Similar articles
-
Incidence of and Risk of Mortality After Hip Fractures in Rheumatoid Arthritis Relative to the General Population.Arthritis Care Res (Hoboken). 2025 May;77(5):604-613. doi: 10.1002/acr.25466. Epub 2024 Dec 22. Arthritis Care Res (Hoboken). 2025. PMID: 39542830 Free PMC article.
-
Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink.Rheumatology (Oxford). 2022 Apr 11;61(4):1448-1458. doi: 10.1093/rheumatology/keab548. Rheumatology (Oxford). 2022. PMID: 34255815 Free PMC article.
-
Fall-related risk factors and osteoporosis in women with rheumatoid arthritis.Rheumatology (Oxford). 2004 Oct;43(10):1267-71. doi: 10.1093/rheumatology/keh304. Epub 2004 Jul 13. Rheumatology (Oxford). 2004. PMID: 15252210
-
[Clinical features of fracture with glucocorticoid induced osteoporosis and rheumatoid arthritis].Clin Calcium. 2006 Nov;16(11):1866-70. Clin Calcium. 2006. PMID: 17079854 Review. Japanese.
-
Management of osteoporosis in rheumatoid arthritis patients.Expert Opin Pharmacother. 2015 Mar;16(4):559-71. doi: 10.1517/14656566.2015.997709. Epub 2015 Jan 27. Expert Opin Pharmacother. 2015. PMID: 25626121 Review.
Cited by
-
The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review.Int J Mol Sci. 2024 Jan 3;25(1):626. doi: 10.3390/ijms25010626. Int J Mol Sci. 2024. PMID: 38203796 Free PMC article. Review.
-
Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study.Osteoporos Sarcopenia. 2020 Jun;6(2):82-87. doi: 10.1016/j.afos.2020.04.003. Epub 2020 May 20. Osteoporos Sarcopenia. 2020. PMID: 32715099 Free PMC article.
-
Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.Osteoporos Int. 2016 Nov;27(11):3239-3249. doi: 10.1007/s00198-016-3646-z. Epub 2016 Jun 8. Osteoporos Int. 2016. PMID: 27273113
-
Verbascoside Inhibits/Repairs the Damage of LPS-Induced Inflammation by Regulating Apoptosis, Oxidative Stress, and Bone Remodeling.Curr Issues Mol Biol. 2023 Oct 31;45(11):8755-8766. doi: 10.3390/cimb45110550. Curr Issues Mol Biol. 2023. PMID: 37998727 Free PMC article.
-
Osteosarcopenia synergistically increases the risk of falls in patients with rheumatoid arthritis.Osteoporos Sarcopenia. 2021 Dec;7(4):140-145. doi: 10.1016/j.afos.2021.11.002. Epub 2021 Dec 4. Osteoporos Sarcopenia. 2021. PMID: 35005250 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical